BioCryst Pharmaceuticals (BCRX) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

BCRX is expected to report earnings to rise 50.00% to -9 cents per share on October 30

BioCryst Pharmaceuticals BCRX Stock Earnings Reports

Q3'24

Est.

$-0.09

Q2'24

Beat

by $0.11

Q1'24

Beat

by $0.04

Q4'23

Missed

by $0.03

Q3'23

Beat

by $0.06

The last earnings report on August 05 showed earnings per share of -5 cents, beating the estimate of -17 cents. With 1.64M shares outstanding, the current market capitalization sits at 1.58B.

View a ticker or compare two or three

Compare

BCRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For BCRX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for BCRX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of small molecule pharmaceuticals

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

4505 Emperor Boulevard

Phone

+1 919 859-1302

Employees

536

Web

https://www.biocryst.com